Gary B. Thurman
Impact in
- Immunology top 1%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
- Immune Response and Inflammation
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
- Immunology 35
- Immunotherapy and Immune Responses 9
- Immune Cell Function and Interaction 9
- T-cell and B-cell Immunology 8
- Macrophage Migration Inhibitory Factor 7
- Immune Response and Inflammation 6
- Oncology 22
- CAR-T cell therapy research 7
- Co-authors
- Allan L. GoldsteinRobert K. OldhamGailen D. MarshallJohn R. YannelliWilliam H. WestKurt W. TauerDouglas OrrPaul M. Newberne
- Journals
- Journal of Immunological Methods (9 papers)The Journal of Immunology (7 papers)Annals of the New York Academy of Sciences (7 papers)Journal of Cancer Research and Clinical Oncology (6 papers)Cancer (3 papers)
- Partner nations
- United StatesItalyRussia
In The Last Decade
Gary B. Thurman
77 papers receiving 3.6k citations
Hit Papers
Peers
Comparison fields: 5 of 168
- Immunology 1.7k
- Oncology 956
- Radiology, Nuclear Medicine and Imaging 555
- Immunology and Allergy 141
- Biotechnology 160
Countries citing papers authored by Gary B. Thurman
This map shows the geographic impact of Gary B. Thurman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary B. Thurman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary B. Thurman more than expected).
Fields of papers citing papers by Gary B. Thurman
This network shows the impact of papers produced by Gary B. Thurman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary B. Thurman. The network helps show where Gary B. Thurman may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Gary B. Thurman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 0 | |
| 2 | 1998 | 11 | |
| 3 | Phase I study of the antineovascularization drug CM101. | 1997 | 35 |
| 4 | 1997 | 5 | |
| 5 | 1996 | 11 | |
| 6 | 1995 | 14 | |
| 7 | 1994 | 3 | |
| 8 | 1994 | 16 | |
| 9 | 1990 | 10 | |
| 10 | 1990 | 6 | |
| 11 | 1989 | 25 | |
| 12 | 1988 | 8 | |
| 13 | 1988 | 12 | |
| 14 | 1976 | 39 | |
| 15 | Thymosin-induced increase in mitogenic responsiveness of lymphocytes of c57bl/6j, nzb/w, and nude mice. | 1975 | 5 |
| 16 | 1975 | 19 | |
| 17 | 1974 | 38 | |
| 18 | 1974 | 70 | |
| 19 | 1973 | 32 | |
| 20 | 1972 | 170 |
About Gary B. Thurman
Gary B. Thurman is a scholar working on Immunology, Oncology, Immunology and Allergy, Radiology, Nuclear Medicine and Imaging and Biotechnology, having authored 79 papers that have together received 4.1k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (10 papers), Immunotherapy and Immune Responses (9 papers), Immune Cell Function and Interaction (9 papers), T-cell and B-cell Immunology (8 papers), CAR-T cell therapy research (7 papers), Macrophage Migration Inhibitory Factor (7 papers), Immune Response and Inflammation (6 papers) and Glycosylation and Glycoproteins Research (5 papers). The work is most often cited by research in Immunology (1.7k citations), Oncology (956 citations), Radiology, Nuclear Medicine and Imaging (555 citations), Immunology and Allergy (141 citations) and Biotechnology (160 citations). Gary B. Thurman has collaborated with scholars based in United States, Italy and Russia. Frequent co-authors include Allan L. Goldstein, Robert K. Oldham, Gailen D. Marshall, John R. Yannelli, William H. West, Kurt W. Tauer, Douglas Orr, Paul M. Newberne, Teresa L. K. Low and Aftab Ahmed. Their work appears in journals such as Journal of Immunological Methods, The Journal of Immunology, Annals of the New York Academy of Sciences, Journal of Cancer Research and Clinical Oncology and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.